Berra Yazar-Klosinski: MDMA ("Ecstasy"), Post-Traumatic Stress Disorder (PTSD), Psychotherapy & MAPS | #26
Mind & Matter
English - June 11, 2021 04:00 - 1 hour - 75.2 MB - ★★★★★ - 15 ratingsScience Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Nick talks to Dr. Berra Yazar-Klosinski, the Chief Science Officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Berra talked about the results of MAPS' recent Phase III clinical trials for treating severe PTSD, how these studies are conducted, and what we know about the underlying biology of Post-Traumatic Stress Disorder (PTSD) and the drug MDMA.
USEFUL LINKS
Sign up for the weekly Mind & Matter newsletter
[https://mindandmatter.substack.com/]
Download the podcast & follow Nick at his website
[https://www.nickjikomes.com]
Buy books by M&M guests
[https://linktr.ee/mindandmatter_books]
Athletic Greens, comprehensive daily nutrition (Free 1-year supply Vitamin D w/ purchase)
[https://athleticgreens.com/partner/d3...]
Organize your digital highlights & notes w/ Readwise (2 months free w/ sub)
[https://readwise.io/nickjikomes/]
Follow & Support Nick's work
[https://linktr.ee/trikomes]
Learn more about our podcast sponsor, Dosist
[https://dosist.com/]
ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.